• The inaugural US E-Cigarette Summit was held in Washington DC, on Monday May 8, 2017 and welcomed over 250 people
  • The 2nd Annual US E-Cigarette Summit will take place April 30, 2018......Registration is now open


Science, Regulation and Public Health

Smoking is the biggest single cause of preventable death in the developed world with almost 1 billion users worldwide. The devastating effect of long-term smoking cannot be underestimated, with approximately half of all lifetime smokers dying from smoking related diseases and many more suffering a compromised quality of life.  Despite decades of successful tobacco control efforts, we are still a long way from ending the smoking epidemic.

The emergence of e-cigarettes, which deliver nicotine but without the vast range of carcinogens and toxins found in combustible tobacco products has created one of the most controversial and contentious public health issues of a generation, with divisions appearing within longstanding professional alliances in both Tobacco Control and Public Health communities, despite a continued shared goal of protecting public health and ending the smoking epidemic.

The E-Cigarette Summit provides a  neutral platform to explore the available peer reviewed evidence and debate the issues that are dividing scientists, health professionals and policy makers alike. So, are-cigarettes a valuable harm reduction strategy or a tacit U-turn on decades of effective tobacco control efforts? Whichever side of the debate you fall on, this is likely to be one of the most significant public health issues for a generation.

2018 Key Topics include:

  • An update on the FDA’s Comprehensive Plan on nicotine and tobacco
  • Update on the NASEM report
  • Nicotine reduction – harm reduction not prohibition
  • The New Zealand experience with e-cigarettes
  • Evolution of the regulatory framework in the UK
  • Publi Health England’s independent expert e-cigarette evidence review
  • The impact of E-Cigarette regulation
  • Safety concerns with E-Cigarettes
  • Prevention and protection policies for youth use of E-Cigarettes and tobacco products
  • Switching from combustibles to E-Cigarettes
  • Developing an economic model to understand the E-Cigarette industry
  • IQOS, E-Cigarettes and tobacco control – harm reduction the japaense way
  • How to make sense of the flavours issue
  • Smoking harm reduction – if not now, when?

2018 Confirmed Speakers/Panel Presenters

Mitch ZellerDirector, Center for Tobacco ProductsAttorney General Tom MillerAttorney General of Iowa
Prof Thomas J. Glynn, PhDAdjunct Lecturer, Stanford Prevention Research Centre, Stanford University School of MedicineProf Hayden McRobbieClinical Director, Dragon Institute for Innovation (NZ), Professor in Public Health Interventions, Queen Mary University, University of London
Dr Robin MermelsteinProfessor of Psychology and IHRP Director, University of Illinois, ChicagoProf K. Michael CummingsCo-Leader Tobacco Research Program, Medical University of South Carolina
Prof Eric A. FeldmanProfessor of Law, Professor of Medical Ethics & Health Policy, University of Pennsylvania Law SchoolDr. Lion ShahabSenior Lecturer/Associate Professor in Health Psychology, University College London
Professor Neal L. Benowitz MDProfessor of Medicine and Bioengineering & Therapeutic Sciences, University of California, San FranciscoDeborah ArnottChief Executive, Action on Smoking and Health (UK)
Professor Ann McNeillProfessor of Tobacco Addiction, UK Centre for Tobacco and Alcohol Studies (UKCTAS), Kings College LondonDavid Abrams PhDProfessor, College of Global Public Health, New York University
Clive BatesDirector, Counterfactual Consulting LtdProf Eric C. DonnyProfessor of Physiology and Pharmacology, Wake Forest School of Medicine
Matthew L. MyersPresident, Campaign for Tobacco-Free Kids
Prof Amy FairchildAssociate Dean of Academic Affairs, Texas A&M School of Public Health
David GrahamChief Impact Officer, NJOYProf Lynn T. KozlowskiProfessor of Community Health and Health Behavior, School of Public Health & Health Professions, University at Buffalo, SUNY
Prof David LevyProfessor, Lombardl Comprehensive Cancer Center, Georgetown University